The Compression Therapy Devices Market will witness a CAGR of 5.2% by reaching US$ 3,232.3 Million from 2021. The new-fangled healthcare electronic technologies like 3D printing, GPS tracking, and wearable biometric devices are being tested concerning clinical use. Cutting-edge technology is expected to be one of the driving forces in the healthcare industry in the subsequent decade.
According to a new market report published by Persistence Market Research “Global Market Study on Compression Therapy – Asia to Witness Highest Growth by 2020”, the global compression therapy market was valued at USD 2,377.8 million in 2014 and is expected to expand at a CAGR of 5.2% from 2014 to 2020, to reach USD 3,232.3 million by 2020.
Compression therapy is a procedure entailing the delivery of an external force to tired and aching legs and other relevant anatomical targets where compression is required for management. This therapy is used to treat venous and lymphatic diseases such as lower limb edema, venous eczema, deep vein thrombosis, and diabetic foot ulcers.
How About Looking Through The Sample Of Compression Therapy Devices Market Report? https://www.persistencemarketresearch.co/samples/3064
Some of the major players in the compression therapy market:
- BSN medical GmbH.
- PAUL HARTMANN AG.
- Julius Zorn GmbH.
- Smith & Nephew plc.
- medi GmbH & Co. KG.
- Medtronic plc.
How About Step-By-Step Insights To Compression Therapy Devices Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/3064
Globally, the market for compression therapy is witnessing significant growth due to the increasing prevalence of diabetes, growth of the aging population, high incidence of sports injuries, rising awareness about various venous diseases, and the advanced features of compression therapy garments and devices.
However, inadequate reimbursement policies and the risk of complications associated with compression therapy systems inhibit the growth of the market. The global compression therapy market is anticipated to grow from an estimated USD 2,377.8 million in 2014 to USD 3,232.3 million by 2020 at a CAGR of 5.2% during the forecast period.
North America dominates the compression therapy market due to increasing numbers of sports injuries in the region. For instance, according to Safe Kids Worldwide, a global organization dedicated to preventing injuries in children, every year about 1.3 million cases of sports injuries among youngsters are registered in the U.S. Increasing prevalence of diabetes, aging population, and rising obesity are also supporting the growth of compression therapy market in North America.
Want To Keep A Tab On The Latest Findings In The Compression Therapy Devices Market? Purchase Our Compression Therapy Devices Market Report Now! https://www.persistencemarketresearch.com/checkout/3064
The compression therapy market in Europe is growing due to rising incidence of sports injuries in the region. According to the European Injury Database (IDB), approximately 4.5 million people above 15 years of age are treated in hospitals for sports injuries every year in the region. In addition, increasing the prevalence of diabetes and the growth of the aging population are also supporting the growth of the compression therapy market in Europe.
Asia is the fastest-growing region in the compression therapy market. According to the Asian Federation of Sports Medicine (AFSM), a part of International Federation of Sports Medicine (FIMS), on average 21,334 sports injuries occur every year in the region. Moreover, a growing aging population and increasing prevalence of diabetes are also supporting the growth of the compression therapy market in the region.
Access Trending Reports:
Membrane Technology Market – The global membrane technology market for pharmaceutical, biopharma and life sciences is estimated at USD 7,029.9 million in 2014 and is expected to grow at a CAGR of 9.1% from 2014 to 2019, to reach an estimated value of USD 10,886.0 million in 2019.
Rare Endocrine Disease Treatment Market – The global rare endocrine disease treatment market will exhibit a moderate expansion in the period between 2017 and 2026, according to a new report of Persistence Market Research (PMR).
Rheumatoid Arthritis Market – Persistence Market Research (PMR) delivers key insights on the Rheumatoid Arthritis Market in its latest report titled ‘Global Market Study on Rheumatoid Arthritis Diagnosis Tests: Increasing Efficiency of RA Test Kits to Drive Growth of the Market during the Forecast Period, 2015 – 2022’.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.